News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

CardioDx, Inc. to Present at the 31st Annual J.P. Morgan Healthcare Conference


1/3/2013 6:41:45 AM

CardioDx, Inc., a pioneer in the field of cardiovascular genomic diagnostics, today announced that the company will present at the 31st Annual J.P. Morgan Healthcare Conference in San Francisco.

David Levison, the company’s President and Chief Executive Officer, will provide an overview of CardioDx and of Corus® CAD, the only clinically validated gene expression test for obstructive coronary artery disease, on Thursday, January 10, 2013 at 10:00 a.m. PT at the Westin St. Francis Hotel.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES